TM D'Eon, KA Pierce, JJ Roix, A Tyler, H Chen … - Diabetes, 2008 - Am Diabetes Assoc RESULTS— For the first time, we provide evidence that insulin is a major
regulator of EC metabolism. Insulin treatment reduced intracellular ECs
(2-arachidonylglycerol [2-AG] and anandamide [AEA]) in 3T3-L1 adipocytes. ... Cited by 14 - Related articles - BL Direct - All 5 versions
I Matias, S Petrosino, A Racioppi, R Capasso, … - Molecular and Cellular Endocrinology, 2008 - Elsevier Increasing evidence indicates that endocannabinoid (EC) signalling is
dysregulated during hyperglycemia and obesity, particularly at the level of
anandamide (AEA) and/or 2-arachidonoylglycerol (2-AG) concentrations in ... Cited by 22 - Related articles - All 2 versions
KM Starowicz, L Cristino, I Matias, R Capasso … - Obesity, 2008 - nature.com Objective: Reduction of cortisone to cortisol is mediated by 11 -hydroxysteroid
dehydrogenase type 1 (11 HSD1), a putative key enzyme in obesity-related
complications. Experimental studies suggest that adipokines, notably leptin ... Cited by 29 - Related articles - All 2 versions
G Murdolo, K Kempf, A Hammarstedt, C … - Journal of endocrinological investigation, 2007 - ncbi.nlm.nih.gov Human obesity has been associated with a dysregulation of the peripheral and
adipose tissue (AT) endocannabinoid system (ES). The aim of this study was to
elucidate the acute in vivo effects of insulin on gene expression of the ... Cited by 14 - Related articles - BL Direct
TMDE PhD, KA Pierce, JJ Roix, AT PhD, HC … - Am Diabetes Assoc Tara MD'Eon PhD, Kerry A Pierce, Jeffery J Roix, Andrew Tyler PhD, Hong Chen
PhD, and Sandra R Teixeira PhD. ... Diabetes and Metabolism Disease Area,
Novartis Institutes for BioMedical Research, Inc., Cambridge, MA, USA 02139. Related articles
- ►endojournals.org C Pagano, C Pilon, A Calcagno, R Urbanet, M … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Experimental Design: We measured expression of type 1 and type 2 cannabinoid
receptors (CNR), enzymes of cannabinoids synthesis and degradation in human
omental, sc abdominal, and gluteal adipose tissue from lean and obese ... Cited by 34 - Related articles - BL Direct - All 3 versions
K Kempf, J Hector, T Strate, B Schwarzloh, B … - Hormone and metabolic research. Hormon-und …, 2007 - ncbi.nlm.nih.gov The aim of the study was to investigate if the endocannabinoid system (ECS) is
activated in visceral adipose tissue and if adipose tissue inflammation affects
the ECS activation state. Therefore, expression of fatty acid amide ... Cited by 16 - Related articles - BL Direct - All 3 versions
- ►physiology.org AW Herling, M Gossel, G Haschke, S … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc The objective of the present study was to investigate in fed Wistar rats whether
the cannabinoid-1 (CB1) receptor antagonist AVE1625 causes primary effects on
metabolic blood and tissue parameters as well as metabolic rate, which are ... Cited by 18 - Related articles - BL Direct - All 4 versions
R Nogueiras, F Rohner-Jeanrenaud, SC … - Journal of Neuroendocrinology, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 6 - Related articles - BL Direct - All 3 versions
I Kunz, MK Meier, A Bourson, M Fisseha, W … - International journal of obesity, 2008 - nature.com Results: Compared with vehicle-treated rats, rats administered 3 and 10 mg kg -
1 rimonabant showed an 18 and 49% increase in O 2 consumption, respectively
after 3 h. A second dose of rimonabant administered 9–14.5 h after the ... Cited by 6 - Related articles - All 5 versions
